| |
KO |
 Metabolism
|
|
|
 Overview
|
|
|
Carbohydrate metabolism
|
|
|
Energy metabolism
|
|
|
Lipid metabolism
|
00061 Fatty acid biosynthesis [PATH:bfu00061]
|
00062 Fatty acid elongation [PATH:bfu00062]
|
00071 Fatty acid degradation [PATH:bfu00071]
|
00072 Synthesis and degradation of ketone bodies [PATH:bfu00072]
|
 00073 Cutin, suberine and wax biosynthesis
|
00100 Steroid biosynthesis [PATH:bfu00100]
|
00120 Primary bile acid biosynthesis
|
00121 Secondary bile acid biosynthesis
|
00140 Steroid hormone biosynthesis
|
00561 Glycerolipid metabolism [PATH:bfu00561]
|
00564 Glycerophospholipid metabolism [PATH:bfu00564]
|
00565 Ether lipid metabolism [PATH:bfu00565]
|
00600 Sphingolipid metabolism [PATH:bfu00600]
|
00590 Arachidonic acid metabolism [PATH:bfu00590]
|
BC1G_14519 hypothetical protein
BC1G_00078 hypothetical protein
BC1G_04254 hypothetical protein
BC1G_09514 hypothetical protein
BC1G_02031 glutathione peroxidase
|
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K14674 TGL4; TAG lipase / steryl ester hydrolase / phospholipase A2 / LPA acyltransferase [EC:3.1.1.3 3.1.1.13 3.1.1.4 2.3.1.51]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K01254 LTA4H; leukotriene-A4 hydrolase [EC:3.3.2.6]
K00432 gpx; glutathione peroxidase [EC:1.11.1.9]
|
00591 Linoleic acid metabolism
|
00592 alpha-Linolenic acid metabolism [PATH:bfu00592]
|
01040 Biosynthesis of unsaturated fatty acids [PATH:bfu01040]
|
01004 Lipid biosynthesis proteins [BR:bfu01004]
|
|
|
Nucleotide metabolism
|
|
|
Amino acid metabolism
|
|
|
Metabolism of other amino acids
|
|
|
Glycan biosynthesis and metabolism
|
|
|
Metabolism of cofactors and vitamins
|
|
|
Metabolism of terpenoids and polyketides
|
|
|
Biosynthesis of other secondary metabolites
|
|
|
Xenobiotics biodegradation and metabolism
|
|
|
Enzyme families
|
|
|
Genetic Information Processing
|
|
|
Environmental Information Processing
|
|
|
Cellular Processes
|
|
|
Organismal Systems
|
|
|
Human Diseases
|
|
|
Cancers
|
|
|
Immune diseases
|
|
|
Neurodegenerative diseases
|
|
|
Substance dependence
|
|
|
Cardiovascular diseases
|
|
|
Endocrine and metabolic diseases
|
|
|
Infectious diseases
|
05110 Vibrio cholerae infection
|
05120 Epithelial cell signaling in Helicobacter pylori infection
|
05130 Pathogenic Escherichia coli infection
|
05132 Salmonella infection
|
05131 Shigellosis
|
05133 Pertussis
|
05134 Legionellosis
|
05150 Staphylococcus aureus infection
|
05152 Tuberculosis
|
05100 Bacterial invasion of epithelial cells
|
05166 HTLV-I infection
|
05162 Measles
|
05164 Influenza A
|
05161 Hepatitis B
|
05160 Hepatitis C
|
05168 Herpes simplex infection
|
05167 Kaposi's sarcoma-associated herpesvirus infection
|
05169 Epstein-Barr virus infection
|
05165 Human papillomavirus infection
|
BC1G_13455 similar to glycogen synthase kinase-3
BC1G_00321 hypothetical protein
BC1G_13067 hypothetical protein
BC1G_15519 similar to cdc42 GTPase
BC1G_08696 serine/threonine protein phosphatase PP2A-2 catalytic subunit
BC1G_10188 hypothetical protein
BC1G_07803 similar to protein phosphatase 2A regulatory B subunit
BC1G_07799 hypothetical protein
BC1G_11880 hypothetical protein
BC1G_03611 hypothetical protein
BC1G_06772 hypothetical protein
BC1G_11001 hypothetical protein
BC1G_00329 hypothetical protein
BC1G_01608 similar to RPD3
BC1G_11969 hypothetical protein
BC1G_03354 transcription initiation factor TFIID
BC1G_01786 hypothetical protein
BC1G_01785 hypothetical protein
BC1G_07606 hypothetical protein
BC1G_10176 similar to ras protein
BC1G_04437 hypothetical protein
BC1G_13966 mitogen-activated protein kinase
BC1G_04254 hypothetical protein
BC1G_10410 hypothetical protein
BC1G_07542 hypothetical protein
BC1G_10057 tubulin gamma chain
BC1G_05305 hypothetical protein
|
K03083 GSK3B; glycogen synthase kinase 3 beta [EC:2.7.11.26]
K11126 TERT; telomerase reverse transcriptase [EC:2.7.7.49]
K11315 TADA3; transcriptional adapter 3
K04393 CDC42; cell division control protein 42
K04382 PPP2C; serine/threonine-protein phosphatase 2A catalytic subunit [EC:3.1.3.16]
K03456 PPP2R1; serine/threonine-protein phosphatase 2A regulatory subunit A
K04354 PPP2R2; serine/threonine-protein phosphatase 2A regulatory subunit B
K11584 PPP2R5; serine/threonine-protein phosphatase 2A regulatory subunit B'
K07203 MTOR; serine/threonine-protein kinase mTOR [EC:2.7.11.1]
K03062 PSMC1; 26S proteasome regulatory subunit T2
K04728 ATM; ataxia telangiectasia mutated family protein [EC:2.7.11.1]
K06640 ATR; serine/threonine-protein kinase ATR [EC:2.7.11.1]
K12236 NFX1; transcriptional repressor NF-X1
K06067 HDAC1_2; histone deacetylase 1/2 [EC:3.5.1.98]
K11407 HDAC6; histone deacetylase 6 [EC:3.5.1.98]
K03120 TBP; transcription initiation factor TFIID TATA-box-binding protein
K02154 ATPeV0A; V-type H+-transporting ATPase subunit a
K02154 ATPeV0A; V-type H+-transporting ATPase subunit a
K03099 SOS; son of sevenless
K07827 KRAS; GTPase Kras
K07827 KRAS; GTPase Kras
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K10389 TUBG; tubulin gamma
K00873 PK; pyruvate kinase [EC:2.7.1.40]
|
05146 Amoebiasis
|
05144 Malaria
|
05145 Toxoplasmosis
|
05140 Leishmaniasis
|
05142 Chagas disease (American trypanosomiasis)
|
05143 African trypanosomiasis
|
|
|
Drug resistance
|
KEGG Orthology (KO) - Botrytis cinerea